Surfactant Protein C-associated interstitial lung disease; three different phenotypes of the same SFTPC mutation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Nogee LM, Dunbar AE III,Wert SE, Askın F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Eng J Med. 2001; doi: 10.1056/NEJM2001.0222.344.0805 .
Willander H, Askarieh G, Landreh M, et al. High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. Proc Natl Acad Sci U S A. 2012;109:2325–9.
Mulugeta S, Maguire JA, Newitt JL, Russo SJ, Kotorashvili A, Beers MF. Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4-and cytochrome c-related mechanisms. Am J Physiol Lung Cell Mol Physiol. 2007; doi: 10.1152/ajplung.00025.2007 .
Hawkins A, Guttentag SH, Deterding R, Funkhouser WK, Goralski JL, Chatterjee S, Mulugeta S, Beers MF. A non-BRICHOS SFTPC mutant (SP-CI73T) linked to interstitial lung disease promotes a late block in macroautophagy disrupting cellular proteostasis and mitophagy. Am J Physiol Lung Cell Mol Physiol. 2015; doi: 10.1152/ajplung.00217.2014 .
Peca D, Boldrini R, Johannson J, Shieh JT, Citti A, Petrini S, Salerno T, Cazzato S, Testa R, Messina F, Onofri A, Cenacchi G, Westermark P, Ullman N, Cogo P, Cutrera R, Danhaive O. Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations. Eur J Hum Genet. 2015; doi: 10.1038/ejhg.2015.45 .
Brasch F, Griese M, Tredano M, Johnen G, Ochs M, Rieger C, Mulugeta S, Muller KM, Bahuau M, Beers MF. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. Eur Respir J. 2004; doi: 10.1183/09031936.04.00000104 .
Stevens PA, Pettenazzo A, Brasch F, Mulugeta S, Baritussio A, Ochs M, Morrison L, Russo SJ, Beers MF. Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal proprotein trafficking resulting from a spontaneous mutation in the surfactant protein C gene. Pediatr Res. 2005; doi: 10.1203/01.PDR.0000147567.02473.5A .
Garmany TH, Wambach JA, Heins HB, Watkins-Torry JM, Wegner DJ, Bennet K, An P, Land G, Saugstad OD, Henderson H, Nogee LM, Cole FS, Hamvas A. Population and disease-based prevalence of the common mutations associated with surfactant deficiency. Pediatr Res. 2008; doi: 10.1203/PDR.0b013e31816fdbeb .
McBee AD, Wegner DJ, Carlson CS et al. Recombination as a mechanism for sporadic mutation in the surfactant protein-C gene. Pediatr Pulmonol. 2008; doi: 10.1002/ppul.20970 .
Beers MF, Hawkins A, Maguire JA, Kotorashvili A, Zhao M, Newitt, JL et al. A nonaggregating surfactant protein C mutant is misdirected to early endosomes and disrupts phospholipid recycling. Traffic. 2011 doi: 10.1111/j.1600-0854.2011.01223.x .
Bush A, Cunningham S, de Blic J, Barbato A, Clement A, Epaud R, Hengst M, Kiper N, Nicholson AG, Wetzke M, Snijders D, Schwerk N, Griese M; chILD-EU Collaboration. European protocols for the diagnosis and initial treatment of interstitial lung disease in children. Thorax. 2015; doi: 10.1136/thoraxjnl-2015-207349 .
Taam Rola A, Jaubert F, Emodn S, Le Bourgeois M, Epaud R, Karila C, Feldmann D, Scheinmann P, De Blic J. Familial interstitial disease with I73T mutation. Pediatr Pulmonol. 2009; doi: 10.1002/ppul.20970 .
Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with surfactant protein C gene (SFPTC) mutation. Pediatr Res. 2007; doi: 10.1203/PDR.0b013e3180a72588 .
Bridges PJ, Xu Y, Na CL, Wong HR, Weaver TE. Adaptation and increased susceptibility to infections associated with constitutive expression of misfolded SP-C. J Cell Biol. 2006; doi: 10.1083/jcb.200508016 .
Glasser SW, Witt TL, Senft AP, Baatz JE, Folger D, Maxfield MD, Akinbi HT, Newton DA, Prows DR, Korfhagen TR. Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol. 2009; doi: 10.1152/ajplung.90640.2008 .
Glasser SW, Senft AP, Maxfield MD, Ruetschilling TL, Baatz JE, Page K, Korfhagen TR. Genetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injury. Respir Res. 2013; doi: 10.1186/1465-9921-14-19 .
Tucker S, Ahl M, Bush A, Westaway D, Huang X, Rogers JT. Pilot study of the reducing effect on amyloidosis in vivo by three FDA pre-approved drugs via the Alzheimer’s APP 5' untranslated region. Current Alzheimer research 2005; doi: 10.2174/156205053585855 .
Beers MF. Inhibition of cellular processing of surfactant protein C by drugs affecting intracellular pH gradients. J Biol Chem. 1996;271:14361–70.
Kurland G, Deterding RR, Hagood JS, Young LR, Brody AS, Castile RG, Dell S, Fan LL, Hamvas A, Hilman BC, Langston C, Nogee LM and Redding GJ. An official American Thoracic Society clinical practice guideline: classification, evaluation and management of childhood Interstitial Lung Disease. Am J Respir Crit Care Med. 2013; doi: 10.1164/rccm.201305-0923ST .